Risk factors for hospitalizations among patients with cirrhosis: A prospective cohort study
Authors:
Open Access
- 17 November 2017
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 12 (11) , e0187176
Abstract
This study was designed to assess unique baseline factors associated with subsequent hospitalizations in a cohort of outpatients with cirrhosis. A cohort of 193 patients with cirrhosis was recruited from an outpatient liver disease clinic at a single, tertiary medical center. Comorbidities, prescription medications, liver disease symptoms and severity, and psychiatric and pain symptoms were assessed at baseline using validated instruments. Inflammatory markers were measured using standardized Luminex assays. Subsequent hospitalizations and the primary admission diagnoses were collected via chart review. Multivariable models were used to evaluate which baseline factors were associated with time to hospitalization and number of hospitalizations. The cohort consisted of 193 outpatients, with an average age of 58±9 and model for end-stage liver disease (MELD) score of 12±5. Over follow-up, 57 (30%) were admitted to the hospital. The factors associated with time to hospitalization included the severity of liver disease (HR/MELD point:1.10, 95% CI:1.04,1.16), ascites (HR: 1.90, 95% CI: 1.01, 3.58), baseline symptoms of depression (HR:2.34, 95% CI:1.28,4.25), sleep medications (HR:1.81, 95% CI:1.01, 3.22) and IL-6 (HR:1.43, 95% CI: 1.10, 1.84). Similarly the number admissions was significantly associated with MELD (IIR: 1.08, CI: 1.07,1.09), ascites (IIR: 4.15, CI:3.89, 4.43), depressive symptoms (IIR:1.54, CI:1.44,1.64), IL-6 (IIR:1.26, CI:1.23,1.30), sleep medications (IIR:2.74, CI:2.57, 2.93), and widespread pain (IIR: 1.61, CI: 1.50, 1.73). In conclusion, consistent with prior studies, MELD and ascites were associated with subsequent hospitalization. However, this study also identified other factors associated with hospitalization including inflammation, depressive symptoms, sleep medication use, and pain.Keywords
Funding Information
- National Institutes of Health (DK063922)
- University of Pittsburgh (Thomas E. Starzl Young Investigator Award)
This publication has 47 references indexed in Scilit:
- Risk Factors for Frequent Readmissions and Barriers to Transplantation in Patients with CirrhosisPLOS ONE, 2013
- Melatonin Levels in Serum and Ascitic Fluid of Patients with Hepatic EncephalopathyGastroenterology Research and Practice, 2012
- Hospital Readmissions Among Patients With Decompensated CirrhosisAmerican Journal of Gastroenterology, 2012
- Alcohol and Substance Use in Liver Transplant PatientsClinics in Liver Disease, 2011
- Incidence and Predictors of 30-Day Readmission Among Patients Hospitalized for Advanced Liver DiseaseClinical Gastroenterology and Hepatology, 2011
- The American College of Rheumatology Preliminary Diagnostic Criteria for Fibromyalgia and Measurement of Symptom SeverityArthritis Care & Research, 2010
- Criterion validity of the Pittsburgh Sleep Quality Index: Investigation in a non-clinical sampleSleep and Biological Rhythms, 2006
- Validation of a combined comorbidity indexJournal of Clinical Epidemiology, 1994
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987
- The Hospital Anxiety and Depression ScaleActa Psychiatrica Scandinavica, 1983